Loading clinical trials...
Loading clinical trials...
Partner-Specific HIV Risk Reduction Intervention for Drug-Using Incarcerated Adolescents
The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.
Incarcerated adolescents represent a group at high risk for health consequences associated with risky sexual behaviors. Condom use is more common with non-main than main sex partners and substance use in conjunction with sexual risk also appears to vary by partner type. The research team will conduct a small randomized trial to pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use. Participants will be randomized to a 5 session HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model, or a 5 session healthy lifestyles psychoeducation intervention, and then reassessed 3 months after their access to the general community is reinstated. The main hypothesis is that participants in the HIV risk reduction intervention condition will have lower levels of sex-related HIV risk behavior and of substance use in conjunction with sexual risk, relative to those in a healthy lifestyles psychoeducation intervention.
Age
15 - 18 years
Sex
ALL
Healthy Volunteers
No
Women & Infants Hospital of Rhode Island
Providence, Rhode Island, United States
Start Date
February 1, 2009
Primary Completion Date
January 1, 2011
Completion Date
January 1, 2011
Last Updated
December 5, 2012
59
ACTUAL participants
Partner-Specific IMB-based HIV risk reduction intervention
BEHAVIORAL
Healthy Lifestyle
BEHAVIORAL
Lead Sponsor
Women and Infants Hospital of Rhode Island
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07072481